Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1,Condition 2a,Condition 2b 1096,"Dutil J, et al., Physiol Genomics 2005 Mar 1;.",vasoconstriction trait,,RS:0000817,SS/Jr,male,98 days,12,,CMO:0001656,receptor-dependent blood vessel maximum contractile force to receptor-independent blood vessel maximum contractile force ratio,,,,34.85,%,2.94,10.1845,MMO:0000207,tissue force analysis utilizing a force transducer,,0.0,isometric force transducer,,,,Kreb's solution perfusate then angiotensin II (0.3-300 umol/l) ,69065,Kreb's solution perfusate,angiotensin II (0.3-300 umol/l) , 1096,"Dutil J, et al., Physiol Genomics 2005 Mar 1;.",vasoconstriction trait,,RS:0000817,SS/Jr,male,98 days,12,,CMO:0001656,receptor-dependent blood vessel maximum contractile force to receptor-independent blood vessel maximum contractile force ratio,,,,104.06,%,4.7,16.2813,MMO:0000207,tissue force analysis utilizing a force transducer,,0.0,isometric force transducer,,,,Kreb's solution perfusate then phenylephrine (1-100 mmol/l) ,69052,Kreb's solution perfusate,phenylephrine (1-100 mmol/l) , 1096,"Dutil J, et al., Physiol Genomics 2005 Mar 1;.",vasoconstriction trait,,RS:0000817,SS/Jr,male,98 days,12,,CMO:0001656,receptor-dependent blood vessel maximum contractile force to receptor-independent blood vessel maximum contractile force ratio,,,,141.72,%,7.73,26.7775,MMO:0000207,tissue force analysis utilizing a force transducer,,0.0,isometric force transducer,,,,Kreb's solution perfusate then phenylephrine (1-100 mmol/l) and NG-nitroarginine methyl ester (100 umol/l) ,69056,Kreb's solution perfusate,phenylephrine (1-100 mmol/l) ,NG-nitroarginine methyl ester (100 umol/l) 1096,"Dutil J, et al., Physiol Genomics 2005 Mar 1;.",vasoconstriction trait,,RS:0000817,SS/Jr,male,98 days,12,,CMO:0001656,receptor-dependent blood vessel maximum contractile force to receptor-independent blood vessel maximum contractile force ratio,,,,50.61,%,5.29,18.3251,MMO:0000207,tissue force analysis utilizing a force transducer,,0.0,isometric force transducer,,,,Kreb's solution perfusate then angiotensin II (0.3-300 umol/l) and NG-nitroarginine methyl ester (100 umol/l) ,69069,Kreb's solution perfusate,angiotensin II (0.3-300 umol/l) ,NG-nitroarginine methyl ester (100 umol/l)